Dr. Judith Carolin Hagedorn, MD

Dr. Hagedorn practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Hagedorn's NPI, 1871754929, was assigned on June 20, 2008. Dr. Hagedorn graduated from Stanford University School of Medicine in 2008. Dr. Hagedorn holds Washington license MD60445171.

Dr. Hagedorn's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Hagedorn's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dr. Hagedorn is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Hagedorn to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hagedorn practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Hagedorn's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Hagedorn is licensed in Washington.

CMS data shows 188 Medicare services from Dr. Hagedorn across 6 procedure codes in 2024, for 116 Medicare patients. Medicare paid $13,914 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Dr. Hagedorn in 2024. The largest group is 65 to 74, with 48 patients. 71% of them have high blood pressure, and 63% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hagedorn's median patient age at 62, with 14% women.

In 2024, Dr. Hagedorn wrote 181 Medicare Part D claims for 45 patients. 88% of them were for generic drugs. CMS names the drug for 122 of them, across 5 drugs with 11 or more claims each, at $15,602 in total drug cost. In 2023, CMS named 144 claims across 5 drugs.

Dr. Hagedorn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hagedorn as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 55 papers to Dr. Hagedorn, published from 2013 to 2024. 2020 was the busiest year, with 9. The most frequent topics are Kidney, Trauma Centers and Injury Severity Score. Dr. Hagedorn has published most often in Urology. Dr. Hagedorn's most frequent co-authors are Alexander Joseuf Skokan, MD, Rachel Anna Moses, MD and Benjamin Newell Breyer, MD.

Dmand AI links Dr. Hagedorn to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Urethral Stricture and Urethral Obstruction.

CMS Open Payments shows 12 general payments to Dr. Hagedorn from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $197.

Dr. Hagedorn graduated from Stanford University School of Medicine in 2008.